An equine cell therapy manufacturing process that uses vertical bioreactors could help the wider industry reduce production and ultimately product costs, according to the authors of a new study. The ...

A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

(MENAFN- EIN Presswire) EINPresswire/ -- The global single-use bioreactors market is projected to be valued at US$ 4.2 billion in 2026 and is forecast to reach US$ 8.5 billion by 2033, expanding at a ...